Do­ing deals in a time of coro­n­avirus: Biotech CEO Bill Haney says 'y­ou fo­cus on the things that make a dif­fer­ence'

Bill Haney counts his bless­ings where he finds them these days.

As CEO of two biotechs — Sky­hawk and Drag­on­fly — he’s had a front row seat to watch the “dra­mat­ic” im­pact the pan­dem­ic can have on op­er­a­tions. But he’s quick to of­fer thanks that no one in his two com­pa­nies — or their fam­i­lies — have yet to be in­fect­ed.

Yet.

“We know this chal­lenge is com­ing for peo­ple we care about, and we’re con­cerned about that,” says Haney.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER